We had an overwhelming amount of interest to present during the company presentations for 2018! Congratulations to the following 25 companies that were selected to present:
BioEclipse Therpaeutics, Inc.
Coyne Scientific, LLC
Hamamtsu University School of Medicine
MDI Therapeutics, Inc.
Oncolytics Biotech, Inc.
“Presenting at Biocom this year helped put Forge on the radar of several investors seeking to put money to work in the antibiotic space. The conference not only gave me the opportunity to meet the interested investors face-to-face but also gave me a platform to describe our funding strategy and growth trajectory, which gave us additional momentum leading to upsizing our Series A round. In fact, after my presentation multiple investors that were ‘circling the hoop’ were now ready to jump into the game and asked if they could participate in the Series A financing.”
Zachary Zimmerman, Ph.D., CEO , Forge Therapeutics, Inc.